A detailed history of Tfc Financial Management transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Tfc Financial Management holds 3 shares of BIO stock, worth $991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$991
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$263.97 - $344.64 $791 - $1,033
3 New
3 $1,000
Q1 2024

Apr 30, 2024

BUY
$304.11 - $351.99 $608 - $703
2 Added 200.0%
3 $1,000
Q4 2023

Jan 25, 2024

SELL
$269.37 - $365.04 $1,616 - $2,190
-6 Reduced 85.71%
1 $0
Q2 2023

Aug 07, 2023

BUY
$359.49 - $486.4 $2,516 - $3,404
7 New
7 $2,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.